Procter & Gamble to acquire supplement maker Thorne for $3.8B in wellness push

Procter & Gamble is acquiring supplement company Thorne for $3.8 billion, a move to strengthen its position in the growing health and wellness market. Thorne, currently owned by private-equity firm L Catterton, sells products such as creatine and prenatal vitamins. The deal reflects a broader trend of consumer giants expanding into the wellness sector to capture resilient consumer spending.